Kevin F Mclaughlin Acceleron Pharma Inc (XLRN) insider trading activity

XLRN Quotes by TradingView
Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held N/A

KEVIN F MCLAUGHLIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
SELL
Disposition due to a tender of shares in a change of control transaction
-
10,681 Reduced 100.0%
0 Common Stock
Sep 24 2021
SELL
Open market or private sale
$861,241 $160.38 p/Share
5,370 Reduced 33.46%
10,681 Common Stock
Sep 24 2021
BUY
Exercise of conversion of derivative security
$220,868 $41.13 p/Share
5,370 Added 25.07%
16,051 Common Stock
Sep 23 2021
SELL
Open market or private sale
$3,155,719 $160.76 p/Share
19,630 Reduced 64.76%
10,681 Common Stock
Sep 23 2021
BUY
Exercise of conversion of derivative security
$735,536 $37.47 p/Share
19,630 Added 39.31%
30,311 Common Stock
Jan 29 2021
BUY
Grant, award, or other acquisition
-
4,868 Added 31.31%
10,681 Common Stock
Jan 05 2021
SELL
Open market or private sale
$183,133 $122.17 p/Share
1,499 Reduced 20.5%
5,813 Common Stock
Jan 04 2021
SELL
Open market or private sale
$407,671 $124.29 p/Share
3,280 Reduced 30.97%
7,312 Common Stock
Jan 04 2021
SELL
Payment of exercise price or tax liability
$77,569 $124.31 p/Share
624 Reduced 5.56%
10,592 Common Stock
Dec 14 2020
SELL
Open market or private sale
$5,534,594 $130.14 p/Share
42,528 Reduced 79.13%
11,216 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$1,488,055 $34.99 p/Share
42,528 Added 44.17%
53,744 Common Stock
Dec 11 2020
SELL
Open market or private sale
$387,500 $125.0 p/Share
3,100 Reduced 21.65%
11,216 Common Stock
Dec 11 2020
BUY
Exercise of conversion of derivative security
$127,720 $41.2 p/Share
3,100 Added 17.8%
14,316 Common Stock
Dec 10 2020
SELL
Open market or private sale
$62,560 $125.12 p/Share
500 Reduced 4.27%
11,216 Common Stock
Dec 10 2020
BUY
Exercise of conversion of derivative security
$17,495 $34.99 p/Share
500 Added 4.09%
11,716 Common Stock
Dec 09 2020
SELL
Open market or private sale
$484,116 $125.03 p/Share
3,872 Reduced 25.66%
11,216 Common Stock
Dec 09 2020
BUY
Exercise of conversion of derivative security
$135,481 $34.99 p/Share
3,872 Added 20.42%
15,088 Common Stock

Also insider at

DBTX
Decibel Therapeutics, Inc. Healthcare
Director
VCEL
Vericel Corp Healthcare
ADGI
Adagio Therapeutics, Inc. Healthcare
KFM

Kevin F Mclaughlin

SVP, CFO and Treasurer
Cambridge, MA

Track Institutional and Insider Activities on XLRN

Follow ACCELERON PHARMA INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XLRN shares.

Notify only if

Insider Trading

Get notified when an Acceleron Pharma Inc insider buys or sells XLRN shares.

Notify only if

News

Receive news related to ACCELERON PHARMA INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XLRN